Edwards Lifesciences Corp’s recently made public that its CVP, JAPAC Lippis Daniel J. unloaded Company’s shares for reported $24560.0 on May 09 ’25. In the deal valued at $74.42 per share,330 shares were sold. As a result of this transaction, Lippis Daniel J. now holds 26,616 shares worth roughly $2.08 million.
Then, Markowitz Wayne sold 268 shares, generating $20,121 in total proceeds. Upon selling the shares at $75.08, the GM & SVP, Surgical now owns 9,299 shares.
Before that, Ullem Scott B. sold 11,250 shares. Edwards Lifesciences Corp shares valued at $837,035 were divested by the CVP, Chief Financial Officer at a price of $74.40 per share. As a result of the transaction, Ullem Scott B. now holds 41,098 shares, worth roughly $3.21 million.
Piper Sandler upgraded its Edwards Lifesciences Corp [EW] rating to an Overweight from a a Neutral in a research note published recently. A number of analysts have revised their coverage, including Stifel’s analysts, who increased its forecast for the stock in late January from “a Hold” to “a Buy”. Wolfe Research also remained covering EW and has decreased its forecast on January 16, 2025 with a “an Underperform” recommendation from previously “Peer perform” rating. BofA Securities revised its rating on December 16, 2024. It rated EW as “a Buy” which previously was an “a Neutral”.
Price Performance Review of EW
On Monday, Edwards Lifesciences Corp [NYSE:EW] saw its stock jump 0.05% to $78.04. Over the last five days, the stock has gained 4.33%. Edwards Lifesciences Corp shares have risen nearly 5.42% since the year began. Nevertheless, the stocks have fallen -13.44% over the past one year.
How much short interest is there in Edwards Lifesciences Corp?
A steep rise in short interest was recorded in Edwards Lifesciences Corp stocks on 2025-04-30, dropping by -1.29 million shares to a total of 8.24 million shares. Yahoo Finance data shows the prior-month short interest on 2025-03-31 was 9.54 million shares. There was a decline of -15.7%, which implies that there is a negative sentiment for the stock.
